Discovery of a Novel P2X2/3 Allosteric Antagonist as an Efficient Bitter Taste Blocker
- 3 August 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (15) , 18856-18868
Abstract
Masking the taste of unpalatable medicines is a key approach to improving treatment compliance, especially with children, where this issue is exacerbated. The P2X2/3 purinergic receptor is a ligand-gated ion channel activated by ATP that relays information from taste cells to the brain. Inhibition of this receptor has been demonstrated to block taste perception in humans and mice, suggesting that the application of a potent and short-lived antagonist directly on the tongue could provide a solution to improve treatment compliance. The previously reported dual P2X3 and P2X2/3 antagonist AF-353 (1) was used as a starting point for our campaign. A novel pyrazolopyrimidine core was identified using a scaffold-hopping strategy, which delivered compound 30 after SAR optimization. This novel antagonist displayed very high activity against P2X2/3, combined with desired physicochemical properties, resulting in a more efficacious taste-blocking effect in mice when compared to AF-353 (1).Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-055340)
This publication has 27 references indexed in Scilit:
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic CoughLung, 2022
- Discovery of 5-methyl-1H-benzo[d]imidazole derivatives as novel P2X3 Receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2022
- Discovery of clinical candidate Sivopixant (S-600918): Lead optimization of dioxotriazine derivatives as selective P2X3 receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2021
- Orodispersible films: Conception to quality by designAdvanced Drug Delivery Reviews, 2021
- FLIPR Calcium Mobilization Assays in GPCR Drug Discovery2021
- That was then, this is now: the development of our knowledge and understanding of P2 receptor subtypesPurinergic Signalling, 2021
- The sweetness and bitterness of childhood: Insights from basic research on taste preferencesPhysiology & Behavior, 2015
- Modulation of Bitter Taste Perception by a Small Molecule hTAS2R AntagonistCurrent Biology, 2010
- Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X3/P2X2/3 antagonist for the treatment of painBioorganic & Medicinal Chemistry Letters, 2009
- Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X3/P2X2/3 antagonist for the treatment of painBioorganic & Medicinal Chemistry Letters, 2009